|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Rights Issue (Via Preemptive Right)
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Other Aspects To Be Notified
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Additional Explanations
|
||||||||||||||||||||||
|
Within the framework of the resolution adopted by the Company's Board of Directors on 24.06.2025: An application has been submitted today (04.07.2025) to the Capital Markets Board (CMB) for the approval of the attached draft prospectus regarding the capital increase through rights issue. Within the Company's registered capital ceiling of TRY 4,000,000,000, it has been resolved to increase the Company's issued capital of TRY 650,000,000 by TRY 1,950,000,000 in cash (through a rights issue) at a rate of 300%, raising the total issued capital to TRY 2,600,000,000. The entire amount of 1,950,000,000 newly issued shares, each with a nominal value of TRY 1.00, will be issued as registered shares without any restriction on the pre-emptive rights of existing shareholders. The draft prospectus has not yet been approved by the Capital Markets Board. Accordingly, the content of the final prospectus to be approved by the Board may differ from the attached draft. This Public Disclosure has been prepared in both Turkish and English. In case of any discrepancies between the two texts, the Turkish version will prevail.
|
||||||||||||||||||||||
|